Retroviral-mediated gene therapy for the differentiation of primary cells into a mineralizing osteoblastic phenotype.

Abstract excerpt

Bone tissue engineering has emerged as a promising strategy for the repair of critical-sized skeletal fractures. However, the clinical application of this approach has been limited by the availability of a robust mineralizing cell source. Non-osteogenic cells, such as skin fibroblasts, are an attractive cell-source alternative because they are easy to harvest from autologous donor skin biopsies and display a high...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Calcification, Physiologic
• Share to Dermis
• Share to Endpoint Determination